Ortho Clinical Diagnostics’ VITROS® Anti-SARS-CoV-2 IgG quantitative antibody test has received the European CE Mark for the evaluation of immune response after infection or vaccination. The test allows physicians to determine the level of immune response of an individual to SARS-CoV-2 after infection or vaccination. This could help track virus transmission, as well as an individual’s antibody levels.
The US Department of Homeland Security (DHS) has awarded four contracts to MRIGlobal. The contract research organisation, has a base period of one year and four one-year option periods to provide Covid-19 testing solutions to ensure workplace safety and reduce exposure risk to the virus. The contracts will include the provision of managed testing services and the molecular diagnostic test kits and testing services and have a shared ceiling value of up to $2bn.
AXIM Biotechnologies’ manufacturing partner Empowered Diagnostics has applied for the emergency approval of ImmunoPass™, a semi-quantitative rapid Covid-19 test, at point-of-care settings across Canada and the European Union (EU). The test enables the detection of Covid-19 neutralising antibodies in whole blood and is also being reviewed by Health Canada for use in the country.